Education
About Us
Working with TipRanks
Follow Us
Procter & Gamble Health Ltd. (IN:PGHL)
:PGHL
PGHL Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹4,912.30 - ₹6,107.55
Previous CloseN/A
Volume2.65K
Average Volume (3M)583.00
Market Cap
₹97.30B
Enterprise Value₹95.51B
Total Cash (Recent Filing)₹2.06B
Total Debt (Recent Filing)₹76.20M
Price to Earnings (P/E)41.5
Beta0.50
Next Earnings
Aug 20, 2025EPS EstimateN/A
Next Dividend Ex-Date
Aug 22, 2025Dividend Yield2.4%
Share Statistics
EPS (TTM)36.86
Shares Outstanding16,599,382
10 Day Avg. Volume539
30 Day Avg. Volume583
Financial Highlights & Ratios
PEG Ratio6.26
Price to Book (P/B)18.11
Price to Sales (P/S)0.00
P/FCF Ratio211.47
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Procter & Gamble Health Ltd. News
PGHL FAQ
What was Procter & Gamble Health Ltd.’s price range in the past 12 months?
Procter & Gamble Health Ltd. lowest stock price was ₹4912.30 and its highest was ₹6107.55 in the past 12 months.
What is Procter & Gamble Health Ltd.’s market cap?
Procter & Gamble Health Ltd.’s market cap is ₹97.30B.
When is Procter & Gamble Health Ltd.’s upcoming earnings report date?
Procter & Gamble Health Ltd.’s upcoming earnings report date is Aug 20, 2025 which is in 28 days.
How were Procter & Gamble Health Ltd.’s earnings last quarter?
Procter & Gamble Health Ltd. released its earnings results on May 29, 2025. The company reported ₹36.86 earnings per share for the quarter, beating the consensus estimate of N/A by ₹36.86.
Is Procter & Gamble Health Ltd. overvalued?
According to Wall Street analysts Procter & Gamble Health Ltd.’s price is currently Overvalued.
Does Procter & Gamble Health Ltd. pay dividends?
Procter & Gamble Health Ltd. pays a Semiannually dividend of ₹140 which represents an annual dividend yield of 2.4%. See more information on Procter & Gamble Health Ltd. dividends here
What is Procter & Gamble Health Ltd.’s EPS estimate?
Procter & Gamble Health Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Procter & Gamble Health Ltd. have?
Procter & Gamble Health Ltd. has 16,599,382 shares outstanding.
What happened to Procter & Gamble Health Ltd.’s price movement after its last earnings report?
Procter & Gamble Health Ltd. reported an EPS of ₹36.86 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.63%.
Which hedge fund is a major shareholder of Procter & Gamble Health Ltd.?
Currently, no hedge funds are holding shares in IN:PGHL
Company Description
Procter & Gamble Health Ltd.
Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemicals in India. It provides over-the-counter products, vitamins, minerals, and supplements. The company offers its products under the Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands. Procter & Gamble Health Limited also exports its pharmaceutical products to Sri Lanka, Nepal, Myanmar, and Maldives. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India B.V.
Technical Analysis
Eveready Industries India Ltd
―
Jyothy Labs Limited
―
Surya Roshni Limited
―
Symphony Limited
―
Zydus Wellness Limited
―